Lesage Anne 4

What Happened

• Anne Lesage, Chief Early Development at Pharvaris (PHVS), exercised stock options and sold shares on June 25, 2026. She exercised (M) option tranches totaling 3,600 underlying shares (1,400 at $2.59 and 900 at $8.05; plus 2,300/1,400/900 reported as derivative-related dispositions) and sold 4,600 shares in the open market in two blocks of 2,300 shares each at a weighted average price of $35.12. The two sales totaled approximately $161,561 (reported as $80,775 and $80,786). Some option-related shares were surrendered/treated as derivative dispositions at $0.00 in connection with the cashless exercise.

Key Details

• Transaction date: June 25, 2026.
• Option exercises recorded: 1,400 shares @ $2.59 (cost $3,626) and 900 shares @ $8.05 (cost $7,245). Additional derivative disposals of 1,400 and 900 shares at $0.00 relate to the exercise/cashless mechanics.
• Open‑market sales: 4,600 shares (two lots of 2,300) at a weighted average price of $35.12; sale prices ranged $35.00–$35.30 per footnote. Total proceeds ≈ $161,561.
• Plan and mechanics: Sales were made pursuant to a Rule 10b5‑1 trading plan (scheduled exercise and sale); the shares sold were in connection with a cashless exercise of options per the filing.
• Shares owned after the transactions: not specified in the provided filing excerpt.
• Filing timeliness: Reported on June 29, 2026 for transactions on June 25, 2026 — the filing appears timely (not marked late).

Context

• This was an option exercise plus immediate sale (cashless exercise) executed under a pre‑arranged 10b5‑1 plan; such sales are typically pre-scheduled and are not direct, discretionary sales by the insider at the time of sale.
• Footnotes: GrayMatters Consulting B.V. is an entity controlled by Dr. Lesage (F3). Vesting schedules noted for the option grants: one grant vested 25% on Apr 6, 2024 with monthly vesting thereafter (F4); another vested 25% on Feb 3, 2021 with monthly vesting thereafter (F5).
• Transaction codes: M = option exercise/conversion, S = open market sale; zero-dollar derivative dispositions reflect shares surrendered or used in the cashless exercise/tax withholding.